Showing results (211-220 of 1,012) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|July 24, 2026
Advancing Prostate Cancer Survivorship Through Transatlantic Consortium Science: The iCCaRE InitiativeFolakemi T Odedina, Roxana Dronca, Kimlin Tam Ashing, et al.
Cancer Research Communications|August 8, 2026
An Integrated Spatial Multi-Omics Workflow for Sequential RNA and Protein Profiling in FFPE Tumor TissueMerrin Mary Eapen, Qanber Raza, Lucy Chhuo, et al.
Cancer Research Communications|August 10, 2026
Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular AnalysesMamta Gupta, Hoon Choi, Thomas Karasic, et al.
Cancer Research Communications|August 13, 2026
Tumor Mutational Burden and Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients Treated with Neoadjuvant ChemotherapyEarle F Burgess, Landon Brown, Michael McCormack, et al.
Cancer Research Communications|August 26, 2026
A Phase 1b/2 Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational BurdenChristine Federspiel Secher, Martin Højgaard, Iben Spanggaard, et al.
Cancer Research Communications|August 31, 2026
Vitronectin enrichment in prostate cancer liver metastases promotes adhesion and survivalJacob Egelberg, Rebecca Kim, Min J Kim, et al.
Cancer Research Communications|September 23, 2026
Breast cancer protective genetic variant common in women of Indigenous American genetic ancestry is a cis-eQTL for RMND1, ARMT1, and CCDC170 in HER2-enriched tumor subtypesValentina A Zavala, Xiaosong Huang, Sandro Casavilca-Zambrano, et al.
Cancer Research Communications|September 30, 2026
Dual CHK1 and WNT inhibition as a synergistic therapy for gastrointestinal neuroendocrine carcinomaHirokazu Kimura, Yoshihiko Sato, Shinichi Yachida
Cancer Research Communications|February 11, 2025
Evaluating the Radiation Sensitivity Index and 12-Chemokine Gene Expression Signature for Clinical Use in a CLIA LaboratoryAnders E Berglund, John Puskas, Sean J Yoder, et al.
Cancer Research Communications|January 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic TargetingJohn R Lozada, Andrew Elliott, Mark G Evans, et al.
Pageof 102